NCT01820117
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,982 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT00233987
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
- University of California Davis Cancer Center Sacramento, California, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States
- Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States
NCT00287872
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00375791
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Investigative Site Berkeley, California, United States
- Investigative Site Duarte, California, United States
- Investigative Site Atlanta, Georgia, United States
- Investigative Site Chicago, Illinois, United States
Completed
Comprehensive Frailty Assessment
NCT02033928
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- The Ohio State University Hospital East Columbus, Ohio, United States
NCT01691807
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Southaven, Mississippi, United States
- Novartis Investigative Site Houston, Texas, United States
- Novartis Investigative Site San Antonio, Texas, United States
NCT03168035
- Conditions
- Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
NCT00401011
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
NCT03040570
- Conditions
- Critical Care, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Great Ormond Street Hospital for Children London, United Kingdom
- St Mary's Hospital London, United Kingdom
- Southampton General Hospital Southampton, United Kingdom
NCT00400686
- Conditions
- Anemia, Blood Protein Disorders, Cardiovascular Diseases, +14 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States